ArticleEuropean heart journal. Case reports2026
Pathological findings of stereotactic cardiac radiotherapy for the treatment of ventricular tachycardia in patients with Chagas disease: case series.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Standardized processing of explanted hearts after stereotactic arrhythmia radiotherapy (Bio-STAR): a STOPSTORM framework and first human findings.European heart journal open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stereotactic arrhythmia radiotherapy (STAR) is a novel, non-invasive therapeutic option for managing ventricular tachycardia (VT), including in patients with chronic Chagas cardiomyopathy (CCC). However, the histopathological substrate underlying its antiarrhythmic effect remains poorly defined, particularly in the Chagas population. This study aims to characterize the myocardial tissue changes following STAR in two CCC patients, evaluated at different time points after treatment. Case summary: Two CCC patients with recurrent VT underwent STAR as part of a multidisciplinary treatment protocol. One patient died 50 days post-STAR, and the other underwent heart transplantation 702 days after the procedure. Myocardial tissue was collected from irradiated and non-irradiated regions. Gross pathology, histological staining (haematoxylin-eosin and Masson's trichrome), and immunohistochemistry for apoptosis markers (p53, Bcl-2, and caspase-3) were performed and analysed by a cardiac pathologist. Macroscopic analysis showed fibrosis in the STAR-targeted areas. Histological evaluation revealed varying degrees of myocyte damage, including cytoplasmic vacuolization and myocytolysis, more pronounced in the early post-STAR case. Extensive fibrosis was present in both cases, but also observed in non-irradiated areas, reflecting underlying CCC pathology. Immunohistochemistry for apoptosis markers was negative in both patients. Conclusion: Stereotactic arrhythmia radiotherapy areas present myocardial changes consistent with acute cellular injury and fibrosis in CCC patients treated for VT. However, apoptotic activity was not detected within the analysed timeframe. Fibrosis was found in both irradiated and non-irradiated areas, and differentiating STAR-induced fibrosis from baseline Chagas-related remodelling remains challenging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.